These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 21468756

  • 21. Association of Allelic Interaction of Single Nucleotide Polymorphisms of Influx and Efflux Transporters Genes With Nonhematologic Adverse Events of Docetaxel in Breast Cancer Patients.
    Jabir RS, Ho GF, Annuar MABA, Stanslas J.
    Clin Breast Cancer; 2018 Oct; 18(5):e1173-e1179. PubMed ID: 29885788
    [Abstract] [Full Text] [Related]

  • 22. Irinotecan pathway genotype analysis to predict pharmacokinetics.
    Mathijssen RH, Marsh S, Karlsson MO, Xie R, Baker SD, Verweij J, Sparreboom A, McLeod HL.
    Clin Cancer Res; 2003 Aug 15; 9(9):3246-53. PubMed ID: 12960109
    [Abstract] [Full Text] [Related]

  • 23. A comparison of the pharmacokinetics and pharmacodynamics of docetaxel between African-American and Caucasian cancer patients: CALGB 9871.
    Lewis LD, Miller AA, Rosner GL, Dowell JE, Valdivieso M, Relling MV, Egorin MJ, Bies RR, Hollis DR, Levine EG, Otterson GA, Millard F, Ratain MJ, Cancer and Leukemia Group B.
    Clin Cancer Res; 2007 Jun 01; 13(11):3302-11. PubMed ID: 17545536
    [Abstract] [Full Text] [Related]

  • 24. Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.
    Miura M, Satoh S, Inoue K, Kagaya H, Saito M, Inoue T, Suzuki T, Habuchi T.
    Eur J Clin Pharmacol; 2007 Dec 01; 63(12):1161-9. PubMed ID: 17906856
    [Abstract] [Full Text] [Related]

  • 25. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
    Cotte S, von Ahsen N, Kruse N, Huber B, Winkelmann A, Zettl UK, Starck M, König N, Tellez N, Dörr J, Paul F, Zipp F, Lühder F, Koepsell H, Pannek H, Montalban X, Gold R, Chan A.
    Brain; 2009 Sep 01; 132(Pt 9):2517-30. PubMed ID: 19605531
    [Abstract] [Full Text] [Related]

  • 26. Influences of ABC transporter and CYP3A4/5 genetic polymorphisms on the pharmacokinetics of lenvatinib in Chinese healthy subjects.
    Li J, Wang X, Ning C, Wang Z, Wang Y, Zheng M, Zhang S, Lu Y, Zhang Y, Li N, Chen X, Zhao D.
    Eur J Clin Pharmacol; 2020 Aug 01; 76(8):1125-1133. PubMed ID: 32382947
    [Abstract] [Full Text] [Related]

  • 27. A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk.
    Campa D, Butterbach K, Slager SL, Skibola CF, de Sanjosé S, Benavente Y, Becker N, Foretova L, Maynadie M, Cocco P, Staines A, Kaaks R, Boffetta P, Brennan P, Conde L, Bracci PM, Caporaso NE, Strom SS, Camp NJ, Cerhan JR, GEC Consortium, Canzian F, Nieters A.
    Int J Cancer; 2012 Aug 15; 131(4):803-12. PubMed ID: 21918980
    [Abstract] [Full Text] [Related]

  • 28. Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes.
    Zamboni WC, Ramanathan RK, McLeod HL, Mani S, Potter DM, Strychor S, Maruca LJ, King CR, Jung LL, Parise RA, Egorin MJ, Davis TA, Marsh S.
    Invest New Drugs; 2006 Sep 15; 24(5):393-401. PubMed ID: 16505951
    [Abstract] [Full Text] [Related]

  • 29. ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients.
    Qu J, Zhou BT, Yin JY, Xu XJ, Zhao YC, Lei GH, Tang Q, Zhou HH, Liu ZQ.
    CNS Neurosci Ther; 2012 Aug 15; 18(8):647-51. PubMed ID: 22630058
    [Abstract] [Full Text] [Related]

  • 30. Association between gene polymorphism and adverse effects in cancer patients receiving docetaxel treatment: a meta-analysis.
    Yan M, Fan X, Si H, Wang X, Wang Z, Wang Z, Lv X, Yin H, Jia Y, Jiang L, Xia Y, Liu Y.
    Cancer Chemother Pharmacol; 2022 Feb 15; 89(2):173-181. PubMed ID: 34988655
    [Abstract] [Full Text] [Related]

  • 31. Effects of splicing-regulatory polymorphisms in ABCC2, ABCG2, and ABCB1 on methotrexate exposure in Chinese children with acute lymphoblastic leukemia.
    Li M, Kong XY, Wang SM.
    Cancer Chemother Pharmacol; 2023 Jan 15; 91(1):77-87. PubMed ID: 36463535
    [Abstract] [Full Text] [Related]

  • 32. Do CYP3A and ABCB1 genotypes influence the plasma concentration and clinical outcome of donepezil treatment?
    Magliulo L, Dahl ML, Lombardi G, Fallarini S, Villa LM, Biolcati A, Scordo MG.
    Eur J Clin Pharmacol; 2011 Jan 15; 67(1):47-54. PubMed ID: 20931330
    [Abstract] [Full Text] [Related]

  • 33. Fexofenadine, a Putative In Vivo P-glycoprotein Probe, Fails to Predict Clearance of the Substrate Tacrolimus in Renal Recipients.
    Vanhove T, Bouillon T, de Loor H, Annaert P, Kuypers D.
    Clin Pharmacol Ther; 2017 Dec 15; 102(6):989-996. PubMed ID: 28437851
    [Abstract] [Full Text] [Related]

  • 34. Population pharmacokinetic analysis of cilostazol in healthy subjects with genetic polymorphisms of CYP3A5, CYP2C19 and ABCB1.
    Yoo HD, Cho HY, Lee YB.
    Br J Clin Pharmacol; 2010 Jan 15; 69(1):27-37. PubMed ID: 20078610
    [Abstract] [Full Text] [Related]

  • 35. Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese.
    Tanabe Y, Shimizu C, Hamada A, Hashimoto K, Ikeda K, Nishizawa D, Hasegawa J, Shimomura A, Ozaki Y, Tamura N, Yamamoto H, Yunokawa M, Yonemori K, Takano T, Kawabata H, Tamura K, Fujiwara Y.
    Cancer Chemother Pharmacol; 2017 Jun 15; 79(6):1179-1186. PubMed ID: 28447211
    [Abstract] [Full Text] [Related]

  • 36. Association of ABCB1, CYP3A4*18B and CYP3A5*3 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis.
    Shi XJ, Geng F, Jiao Z, Cui XY, Qiu XY, Zhong MK.
    J Clin Pharm Ther; 2011 Oct 15; 36(5):614-24. PubMed ID: 21916909
    [Abstract] [Full Text] [Related]

  • 37. Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients.
    Fajac A, Gligorov J, Rezai K, Lévy P, Lévy E, Selle F, Beerblock K, Avenin D, Saintigny P, Hugonin S, Bernaudin JF, Lokiec F.
    Br J Cancer; 2010 Aug 10; 103(4):560-6. PubMed ID: 20628376
    [Abstract] [Full Text] [Related]

  • 38. Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients.
    Cho JH, Yoon YD, Park JY, Song EJ, Choi JY, Yoon SH, Park SH, Kim YL, Kim CD.
    Transplant Proc; 2012 Jan 10; 44(1):109-14. PubMed ID: 22310591
    [Abstract] [Full Text] [Related]

  • 39. Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients.
    Qian CY, Zheng Y, Wang Y, Chen J, Liu JY, Zhou HH, Yin JY, Liu ZQ.
    Chin J Cancer; 2016 Sep 02; 35(1):85. PubMed ID: 27590272
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics and toxicity of docetaxel: role of CYP3A, MDR1, and GST polymorphisms.
    Tran A, Jullien V, Alexandre J, Rey E, Rabillon F, Girre V, Dieras V, Pons G, Goldwasser F, Tréluyer JM.
    Clin Pharmacol Ther; 2006 Jun 02; 79(6):570-80. PubMed ID: 16765145
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.